The Clorox Company (CLX) stock has been trending up the charts in the past six months, recording a gain of 20.5%. This gain comfortably outpaces the broader Consumer Staples sector’s rise of 3.2% and the Zacks Consumer Products - Staples industry’s growth of 2.2% in the same period. CLX’s shares also surpassed the S&P 500 index’s appreciation of 11.8% in the six-month time period.The company has been gaining from pricing and cost-saving initiatives, which have been boosting the gross margins for a while. It ...

Core Insights - Three companies, Walmart, Clorox, and Kenvue, have raised their dividends for at least 40 consecutive years, attracting investors seeking passive income and stability [1] Group 1: Walmart - Walmart's stock has increased by 42.5% over the past six months, driven by strong performance in its U.S. business, which reported 5.3% comparable sales growth and significant market share gains among households earning over $100,000 [2][5] - The company has successfully attracted higher-income consumers while maintaining everyday value for all customers, which has contributed to its stock performance [4][6] - Walmart has implemented AI and machine learning to enhance customer insights and improve its services, including Walmart+ and Walmart Marketplace [7] - Despite a lower yield of 1%, Walmart is a Dividend King with 51 consecutive years of dividend increases, having raised its dividend by 9% in February [8] Group 2: Clorox - Clorox has also raised its dividend for 40 consecutive years, currently offering a yield of 2.9%, but faces challenges in its business performance [9] - The company reported a 20% decline in sales and a 75% drop in diluted earnings per share in its first quarter of fiscal 2024, largely due to overestimating demand during the pandemic and a cyberattack [10][13] - Clorox has raised its full-year fiscal 2025 earnings guidance, indicating a potential return to growth, although its stock price has only increased by 12.8% over the last five years [11][13] - The stock may be appealing for investors looking for higher-yield options in the consumer staples sector, despite the need for improvement in its margins [14] Group 3: Kenvue - Kenvue, spun off from Johnson & Johnson, is positioned as a stable company with a focus on personal health solutions, inheriting J&J's status as a Dividend King [15][17] - The company has experienced a 10.5% decline since its inception, following an initial sell-off, but offers a yield of 3.4% and a forward P/E ratio of 21.1 [16][17] - Kenvue's recent dividend increase was only 2.5%, indicating the need for larger raises to attract passive income investors [17]

Investing in equal parts of these three stocks produces an average dividend yield of 4.6%.With just one month left in the year, now is the perfect time for investors to conduct a portfolio review and update their watch lists for top stocks to buy now. But with the broader stock market indexes around all-time highs, it has become increasingly harder to scoop up shares of quality companies in the bargain bin.When stock prices outpace dividend growth rates, it pushes dividend yields down. In fact, the S&P 500 ...

The Clorox Company (CLX) has been gaining from pricing and cost-saving initiatives, which have been boosting the gross margins for a while. The company’s efforts to expand its international foothold also bode well.In addition, the company has been strengthening its competitive advantage, accelerating profitable growth and preparing for long-term success, while also recovering from the cyber-attack seen earlier in the year. It has fully restored its distribution capabilities and reclaimed the majority of los ...

Core Viewpoint - Clorox's recent earnings report shows significant recovery and growth, driven by improved sales and cost management, despite previous challenges from a cyberattack and divestitures [2][3][4]. Financial Performance - Clorox reported adjusted EPS of $1.86, a substantial increase from $0.49 in the same quarter last year, exceeding the Zacks Consensus Estimate of $1.36 [3]. - Net sales reached $1.76 billion, a 27% increase year-over-year, surpassing the Zacks Consensus Estimate of $1.63 billion [4]. - Organic sales grew by 31% year-over-year, with double-digit growth across all segments [4]. Segment Analysis - The Health and Wellness segment saw sales rise 38% year-over-year to $698 million, driven by volume growth and a favorable mix [6]. - The Household segment's sales improved 38% year-over-year to $447 million, primarily due to volume growth [7]. - The Lifestyle segment reported a 40% increase in sales to $320 million, benefiting from improved volume [8]. - The International segment experienced a 4% decline in sales to $259 million, attributed to the divestiture of the Argentina business and adverse currency rates [9]. Margin and Cost Management - Gross margin expanded by 740 basis points year-over-year to 45.8%, marking the eighth consecutive quarter of margin expansion [5]. - The company implemented a comprehensive margin management program, contributing to its capacity for growth [5]. Guidance and Future Outlook - Clorox expects fiscal 2025 net sales to be flat to down 2%, with organic sales anticipated to increase by 3-5% [11]. - The gross margin is projected to improve by 100-150 basis points, despite cost inflation and higher promotional expenses [12]. - Adjusted EPS guidance for fiscal 2025 has been revised to $6.65-$6.90, indicating an 8-12% year-over-year increase [13]. Market Position and Sentiment - Clorox's stock has gained approximately 5.4% since the last earnings report, outperforming the S&P 500 [1]. - The consensus estimate for Clorox has trended downward by 9.75% recently, reflecting a shift in market sentiment [14][15]. - Clorox holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [17].

Shares of Clorox (CLX) have been strong performers lately, with the stock up 8.1% over the past month. The stock hit a new 52-week high of $171.35 in the previous session. Clorox has gained 18.7% since the start of the year compared to the 4.1% move for the Zacks Consumer Staples sector and the 63.3% return for the Zacks Consumer Products - Staples industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in a ...

Core Insights - CloroxPro's Clorox EcoClean Disinfecting Wipes have been awarded the 2024 ISSA Environment & Sustainability Innovation of the Year Award, recognizing their contribution to maintaining clean and healthy facilities using eco-friendly ingredients [2][4]. Product Launch and Features - The Clorox EcoClean Disinfecting Wipes were launched in August 2024, expanding the EcoClean product lineup which includes disinfecting cleaner, all-purpose cleaner, and glass cleaner [5]. - These wipes are made with naturally derived ingredients, featuring a 100% plant-based substrate and citric acid as the active ingredient, effectively killing 99.9% of illness-causing germs, including Norovirus and COVID-19 [5][9]. - All products in the EcoClean portfolio utilize 25% post-consumer recycled plastic packaging, aiding facilities in achieving sustainability goals aligned with various programs such as LEED and ISSA CIMS - Green Building [5]. Industry Recognition - Clorox EcoClean Disinfecting Wipes join a list of previously recognized CloroxPro products that have won ISSA awards, highlighting the company's ongoing commitment to innovation in the cleaning industry [6]. Company Background - CloroxPro, part of The Clorox Company, has a long-standing legacy in cleaning and disinfecting, providing trusted brand names for commercial cleaning across various sectors, including healthcare, offices, and schools [7][8].

Core Insights - The Clorox Company has elected Stephen Bratspies and Pierre Breber to its board of directors, enhancing its leadership with operational and financial expertise aligned with strategic priorities [1][4]. Group 1: Board Members' Backgrounds - Stephen Bratspies, 57, has extensive executive leadership experience, including as CEO of Hanesbrands, and brings operational, merchandising, and marketing expertise from roles at Walmart, Specialty Brands, and PepsiCo [2]. - Pierre Breber, 60, has a strong financial and accounting background, having served as CFO at Chevron, and possesses experience in strategic transformation and growth initiatives [3]. Group 2: Board Structure and Committees - Bratspies is expected to serve on the Audit committee, while Breber will serve on both the Audit and the Nominating, Governance, and Corporate Responsibility committees [4]. - The current number of board members has increased to 11 following the election, with three previous members not standing for re-election [4]. Group 3: Company Overview - The Clorox Company, headquartered in Oakland, California, has been recognized for its commitment to sustainability, ranking No. 1 on Barron's 100 Most Sustainable Companies list for the second consecutive year in 2024 [5]. - The company offers a range of trusted brands, including Clorox®, Brita®, and Burt's Bees®, and has integrated ESG into its business reporting since 1913 [5].

Clorox is perfect for risk-averse investors or retirees looking to supplement income.Clorox (CLX 1.14%) has been far from a boring household cleaning company as of late. In the second half of 2024, Clorox is up 21% -- a red-hot run that is even better than Nvidia during that period. Here's why Clorox is impressing Wall Street and why the dividend stock could still be worth buying now. It's generating sales growth and margin expansionClorox investors have been on a roller-coaster ride in recent years. As you ...

The Clorox Company’s (CLX) shares have risen 3.8% in the past week following its robust first-quarter results and raised earnings per share (EPS) view for fiscal 2025. Also, the company has made a successful recovery from the cyberattack-related headwinds in the prior year. The company delivered its eighth consecutive quarter of gross-margin expansion, with the metric increasing 740 basis points (bps) in the most recent quarter. Growth was driven by substantial cost savings and a comprehensive margin manage ...